Table 2 Medication outcome with Metformin use.
Parameters (N = 501) | Metformin N(%) | ||
|---|---|---|---|
Monotherapy | Combination | χ 2 value | |
Monitoring | |||
Fasting Plasma glucose | 105 (20.9) | 396 (79.1) | 0.001 |
Controlled | 44 (41.9) | 92 (23.2) | |
Uncontrolled | 61 (58.1) | 304 (76.8) | |
Adverse Effects | |||
Nausea | - | 1 (0.3) | |
Bloating | - | 4 (1.0) | |
Diarrhea | 1 (0.9) | 3 (0.8) | |
Headache | - | 1 (0.3) | |
Weakness | - | 4 (1.0) | |
No adverse effects | 104 (99.1) | 383 (96.6) | 0.023 |
Hypertension complication | |||
YES | 86 (81.9) | 303 (76.5) | 0.001 |
NO | 19 (18.1) | 93 (23.5) | |